glossary       media library       contact us
Print   Text Size   Email
close

Site Map

  • Home
  • About Alnylam
    • Overview
    • People
      • Management
      • Board of Directors
      • Scientific Advisory Board
    • Culture
    • Careers
      • Current Openings
      • Work @ Alnylam
  • Leadership in RNAi
    • Overview
    • Publications
    • About RNAi
      • About RNAi
      • RNAi as a Therapy
      • Advantages of RNAi
    • RNA opportunities
      • microRNAs
      • RNAa
    • Biotherapeutics
  • Programs & Pipeline
    • Pipeline
    • Programs
      • RSV
      • Liver Cancer
      • Hypercholestoralemia
      • TTR Amyloidosis
      • Huntington's
      • Other Preclinical
    • Delivery
    • Product Platform
  • Intellectual Property
    • Overview
    • Patent Estate
    • Patent Pool
  • Business Development
    • Business Development
    • Strategic Alliances
    • InterfeRx and Reagent Licenses
    • Delivery and Licensing Partnerships
    • New Ventures
    • Foundations and Research
  • Events & Media Library
    • Events
    • Media Library
    • News
    • Media Kit
  • Investors
    • Overview
    • Stock Information
    • Corporate Governance
    • SEC Filings
    • Fundamentals
    • Shareholder Information
    • Earnings Estimates
    • Ownership Profile Page
    • Online Investor Kit
    • News
    • Annual Meeting
    • Webcasts
Home     About Alnylam     Leadership in RNAi     Programs & Pipeline     Intellectual Property     Business Development     Events & Media Library     Investors
Legal     Site Map   Copyright © 2008 Alnylam Pharmaceuticals, Inc. All Rights Reserved